University Hospital of Oulu
Oulu, Finland
Location status: Recruiting
Location contact
Erika Jääskeläinen, MD, PhD
CONTACT
Erika Jääskeläinen, MD, PhD
PRINCIPAL_INVESTIGATOR
Jenni Vähä, MSc
CONTACT
NCT Number: NCT06659211
The effects of psychological treatment, mentalization-based therapy, will be studied among persons with mental disorders seeking help from mental health care services.
Interested in participating?
Request Info18 year–64 year
All sexes
Interventional
Not applicable
Oulu, Finland
Location status: Recruiting
Erika Jääskeläinen, MD, PhD
CONTACT
Erika Jääskeläinen, MD, PhD
PRINCIPAL_INVESTIGATOR
Jenni Vähä, MSc
CONTACT
Background: Mentalization-based therapy (MBT) has a growing evidence base as a group treatment, and research on MBT as an individual treatment is needed. This study will provide crucial new information on its effectiveness and usability in everyday patient care.
Methods: The study design will be an non-randomized clinical pilot study. We will study the effectiveness of MBT and analyze which factors are associated with better effectiveness. The length of intervention will be 12 months. The primary outcome measure is the change in psychological symptoms and well-being from the beginning to the end of MBT treatment, measured by CORE-OM. Secondary outcomes include several measures of symptoms, functioning, quality of life, and mentalization. Outcomes will be assessed at 6, 12 and 18 months. The study group will comprise of 64 patients receiving MBT. For comparison, patient group (n=64) with similar characteristics (age, gender, diagnosis) receiving treatment as usual (TAU) in psychiatric services will be ascertained from medical records, and their outcomes after 12 months of treatment will be compared to that of MBT -group.
Intervention / Treatment: Behavioral: Mentalization-based treatment/therapy
Participation criteria: Patients are not strictly limited to a specific disease/diagnostic group. This choice has been made because there is an increasing need in the mental health care for the treatment and therapy of this multi-symptom and severely symptomatic patient group, which also makes the results of the study more applicable to a real life. Patients will be selected for the MBT and TAU based on inclusion and exclusion criteria and patients preference. In addition, the selection to MBT will be made by a trained MBT therapist, who will assess the patient's suitability for MBT (e.g., patient willing to engage in active psychotherapeutic work, interested in the inner world of experience, willing to work interactively).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
MBT Group:
TAU group:
Exclusion criteria
MBT Group:
The exclusion criteria, therefore, do not exclude psychotic disorders or any other psychiatric illness (except substance abuse disorders).
TAU group:
MBT is conducted according to the treatment manual developed by Bateman & Fonagy. Patients are offered weekly individual sessions with an MBT therapist for 12 months.
The TAU group will receive treatment as usual, which in mental health services might include medication, supportive counseling, short therapy, and other limited psychotherapeutic treatments such as DKT. There is no requirement for a frequency of visits for the usual psychiatric care of the TAU group, as this would not be realistic in the current service system, and the usual treatment would not be the usual treatment currently provided.
Time frame: baseline, 6, 12 and 18 months
A self-report measure of psychological distress and symptoms. Higher scores indicates worse outcomes. Includes four main domains: wellbeing, problems, functioning and risk (to self or others).
Based on detailed instructions on calculating the scores, clinical score minimun 0 and maximum 40.
Time frame: baseline, 6, 12 and 18 months
questionnaire assessing personality
Time frame: baseline, 6, 12 and 18 months
Questionnaire on interpersonal problems
Time frame: baseline, 6, 12, and 18 months
Measures experiences in close relationships
Time frame: baseline, 6, 12, and 18 months
Questionnaire on self-esteem
Time frame: baseline, 6, 12 and 18 months
Measure of emotion regulation
Time frame: baseline, 6, 12 and 18 months
Questionnaire on perceived capacity of mentalising oneself and others.
Time frame: baseline, 6, 12 and 18 months
a brief measure of reflective functioning, i.e. mentalizing
Time frame: baseline, 6, 12 and 18 months
WHO 1 question
Time frame: baseline, 12 months
Interview based rating of depression symptoms and their severity. Minimum: 0 Maximum: 60 Higher scores indicate more severe symptoms.
Time frame: baseline, 12 months
Clinician/investigator rated measure of social and occupational functioning. Minimum value: 0 (Inadequate information), 1 (worst functioning, unable to function, persistent inability) Maximum value: 100 (Superior functioning in a wide range of activities)
Time frame: baseline, 12 months
Clinical Global Impression of the severity of illness. Minimum value: 1 (normal, not at all ill) Maximum value: 7 (amongst the most severely ill)
Time frame: baseline, 6 and 12 months
Questionnaire on therapeutic alliance. Higher scores indicate better alliance.
Time frame: from baseline to 18 months
from questionnaires and medical records
Time frame: 6 and 12 months
questions on how the patient has experienced the intervention, and if he/she has experienced the treatment as beneficial
Time frame: 12 and 18 months
Questions on experience of change of health status and recovery
Time frame: from baseline to 12 months
Information collected from the medical records. Data on physical symptoms or diagnosed physical illnesses, that the patient complains or seeks help will be collected from the medical records (visits to mental health care and somatic care).
Time frame: from baseline to 12 months
Number of outpatient, inpatient and emergency visits. Data from medical records.
Time frame: from baseline to 12 months
Use of psychiatric medications. Data from medical records.
Contact information is provided by the study sponsor or research team.
Oulu University Hospital
Other
Effectiveness of Mentalization-based Therapy (MBT) as Part of a Stepped Mental Health Care in Finland - a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06743711
Behavior, Bipolar Affective Disorder
Glostrup Municipality, Denmark
View Trial DetailsNCT07360665
Mental Disorders, Psychotic Disorders
Vila Real, Portugal
View Trial DetailsNCT07316803
Behavior, Bipolar Disorder
Épinay-sur-Seine, Île-de-France Region, France
View Trial DetailsNCT06914622
Mental Disorders, Severe Mental Disorder
Brescia, Italy
View Trial Details